Intrinsic value of CNO Financial Group - CNO

Previous Close

$19.78

  Intrinsic Value

$0.00

stock screener

  Rating & Target

str. sell

-100%

Previous close

$19.78

 
Intrinsic value

$0.00

 
Up/down potential

-100%

 
Rating

str. sell

Our model is not good at valuating stocks of financial companies, such as CNO.

We calculate the intrinsic value of CNO stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2017), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 3.4

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046
   2047

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  7.80
  7.52
  7.27
  7.04
  6.84
  6.65
  6.49
  6.34
  6.21
  6.08
  5.98
  5.88
  5.79
  5.71
  5.64
  5.58
  5.52
  5.47
  5.42
  5.38
  5.34
  5.31
  5.28
  5.25
  5.22
  5.20
  5.18
  5.16
  5.15
  5.13
Revenue, $m
  4,632
  4,981
  5,342
  5,719
  6,110
  6,516
  6,939
  7,379
  7,837
  8,314
  8,810
  9,328
  9,868
  10,432
  11,021
  11,635
  12,277
  12,948
  13,650
  14,384
  15,153
  15,957
  16,798
  17,680
  18,604
  19,571
  20,585
  21,648
  22,762
  23,930
Variable operating expenses, $m
  3,613
  3,885
  4,167
  4,461
  4,766
  5,083
  5,412
  5,755
  6,113
  6,485
  6,872
  7,276
  7,697
  8,137
  8,596
  9,075
  9,576
  10,100
  10,647
  11,220
  11,819
  12,446
  13,103
  13,790
  14,511
  15,266
  16,056
  16,885
  17,754
  18,666
Fixed operating expenses, $m
  345
  353
  361
  369
  377
  385
  394
  402
  411
  420
  429
  439
  449
  458
  468
  479
  489
  500
  511
  522
  534
  546
  558
  570
  582
  595
  608
  622
  635
  649
Total operating expenses, $m
  3,958
  4,238
  4,528
  4,830
  5,143
  5,468
  5,806
  6,157
  6,524
  6,905
  7,301
  7,715
  8,146
  8,595
  9,064
  9,554
  10,065
  10,600
  11,158
  11,742
  12,353
  12,992
  13,661
  14,360
  15,093
  15,861
  16,664
  17,507
  18,389
  19,315
Operating income, $m
  674
  743
  815
  889
  967
  1,048
  1,133
  1,221
  1,313
  1,409
  1,509
  1,613
  1,723
  1,837
  1,956
  2,081
  2,212
  2,349
  2,492
  2,642
  2,800
  2,965
  3,138
  3,320
  3,510
  3,710
  3,920
  4,141
  4,372
  4,615
EBITDA, $m
  4,182
  4,514
  4,860
  5,220
  5,594
  5,983
  6,388
  6,809
  7,248
  7,705
  8,181
  8,678
  9,196
  9,737
  10,302
  10,892
  11,509
  12,154
  12,829
  13,536
  14,275
  15,049
  15,860
  16,709
  17,599
  18,532
  19,510
  20,535
  21,610
  22,738
Interest expense (income), $m
  0
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
  1,504
Earnings before tax, $m
  -830
  -761
  -690
  -615
  -537
  -456
  -371
  -283
  -191
  -95
  5
  109
  218
  333
  452
  577
  708
  844
  988
  1,138
  1,296
  1,461
  1,634
  1,816
  2,006
  2,206
  2,416
  2,637
  2,868
  3,111
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  1
  29
  59
  90
  122
  156
  191
  228
  267
  307
  350
  394
  441
  490
  542
  596
  652
  712
  774
  840
Net income, $m
  -830
  -761
  -690
  -615
  -537
  -456
  -371
  -283
  -191
  -95
  3
  80
  159
  243
  330
  421
  517
  616
  721
  831
  946
  1,066
  1,193
  1,325
  1,465
  1,611
  1,764
  1,925
  2,094
  2,271

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Adjusted assets (=assets-cash), $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Revenue / Adjusted assets
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
Average production assets, $m
  35,079
  37,717
  40,459
  43,307
  46,268
  49,347
  52,548
  55,880
  59,347
  62,958
  66,721
  70,643
  74,734
  79,003
  83,459
  88,113
  92,976
  98,059
  103,374
  108,933
  114,751
  120,840
  127,215
  133,891
  140,885
  148,213
  155,891
  163,940
  172,377
  181,223
Working capital, $m
  -30,466
  -32,757
  -35,138
  -37,612
  -40,183
  -42,857
  -45,637
  -48,530
  -51,542
  -54,678
  -57,946
  -61,352
  -64,905
  -68,612
  -72,482
  -76,524
  -80,747
  -85,162
  -89,778
  -94,606
  -99,659
  -104,947
  -110,484
  -116,282
  -122,356
  -128,720
  -135,388
  -142,378
  -149,706
  -157,389
Total debt, $m
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
  27,854
Total liabilities, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total equity, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total liabilities and equity, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Debt-to-equity ratio
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
Adjusted equity ratio
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000
  0.000

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -830
  -761
  -690
  -615
  -537
  -456
  -371
  -283
  -191
  -95
  3
  80
  159
  243
  330
  421
  517
  616
  721
  831
  946
  1,066
  1,193
  1,325
  1,465
  1,611
  1,764
  1,925
  2,094
  2,271
Depreciation, amort., depletion, $m
  3,508
  3,772
  4,046
  4,331
  4,627
  4,935
  5,255
  5,588
  5,935
  6,296
  6,672
  7,064
  7,473
  7,900
  8,346
  8,811
  9,298
  9,806
  10,337
  10,893
  11,475
  12,084
  12,722
  13,389
  14,089
  14,821
  15,589
  16,394
  17,238
  18,122
Funds from operations, $m
  2,677
  3,010
  3,356
  3,716
  4,090
  4,479
  4,884
  5,305
  5,744
  6,201
  6,676
  7,144
  7,633
  8,143
  8,676
  9,232
  9,814
  10,422
  11,058
  11,724
  12,421
  13,150
  13,914
  14,715
  15,553
  16,432
  17,353
  18,319
  19,331
  20,393
Change in working capital, $m
  -2,204
  -2,291
  -2,381
  -2,474
  -2,572
  -2,674
  -2,781
  -2,893
  -3,011
  -3,136
  -3,268
  -3,406
  -3,553
  -3,707
  -3,870
  -4,042
  -4,223
  -4,414
  -4,616
  -4,828
  -5,052
  -5,288
  -5,537
  -5,798
  -6,074
  -6,364
  -6,669
  -6,990
  -7,328
  -7,683
Cash from operations, $m
  4,882
  5,301
  5,737
  6,190
  6,662
  7,153
  7,664
  8,198
  8,755
  9,337
  9,943
  10,550
  11,186
  11,850
  12,546
  13,274
  14,037
  14,837
  15,674
  16,553
  17,473
  18,439
  19,451
  20,513
  21,627
  22,796
  24,022
  25,309
  26,659
  28,076
Maintenance CAPEX, $m
  -3,254
  -3,508
  -3,772
  -4,046
  -4,331
  -4,627
  -4,935
  -5,255
  -5,588
  -5,935
  -6,296
  -6,672
  -7,064
  -7,473
  -7,900
  -8,346
  -8,811
  -9,298
  -9,806
  -10,337
  -10,893
  -11,475
  -12,084
  -12,722
  -13,389
  -14,089
  -14,821
  -15,589
  -16,394
  -17,238
New CAPEX, $m
  -2,537
  -2,638
  -2,741
  -2,849
  -2,961
  -3,078
  -3,202
  -3,331
  -3,468
  -3,611
  -3,763
  -3,922
  -4,091
  -4,269
  -4,456
  -4,654
  -4,863
  -5,083
  -5,315
  -5,560
  -5,817
  -6,089
  -6,375
  -6,676
  -6,994
  -7,327
  -7,679
  -8,048
  -8,437
  -8,846
Cash from investing activities, $m
  -5,791
  -6,146
  -6,513
  -6,895
  -7,292
  -7,705
  -8,137
  -8,586
  -9,056
  -9,546
  -10,059
  -10,594
  -11,155
  -11,742
  -12,356
  -13,000
  -13,674
  -14,381
  -15,121
  -15,897
  -16,710
  -17,564
  -18,459
  -19,398
  -20,383
  -21,416
  -22,500
  -23,637
  -24,831
  -26,084
Free cash flow, $m
  -909
  -845
  -776
  -705
  -630
  -553
  -472
  -388
  -300
  -209
  -115
  -44
  31
  108
  189
  274
  363
  456
  554
  656
  762
  874
  992
  1,115
  1,244
  1,380
  1,522
  1,671
  1,828
  1,992
Issuance/(repayment) of debt, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total cash flow (excl. dividends), $m
  -909
  -845
  -776
  -705
  -630
  -553
  -472
  -388
  -300
  -209
  -115
  -44
  31
  108
  189
  274
  363
  456
  554
  656
  762
  874
  992
  1,115
  1,244
  1,380
  1,522
  1,671
  1,828
  1,992
Retained Cash Flow (-), $m
  -830
  -761
  -690
  -615
  -537
  -456
  -371
  -283
  -191
  -95
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  -830
  -761
  -690
  -615
  -537
  -456
  -371
  -283
  -191
  -95
  0
  0
  31
  108
  189
  274
  363
  456
  554
  656
  762
  874
  992
  1,115
  1,244
  1,380
  1,522
  1,671
  1,828
  1,992
Discount rate, %
  15.10
  15.86
  16.65
  17.48
  18.35
  19.27
  20.24
  21.25
  22.31
  23.43
  24.60
  25.83
  27.12
  28.47
  29.90
  31.39
  32.96
  34.61
  36.34
  38.16
  40.06
  42.07
  44.17
  46.38
  48.70
  51.13
  53.69
  56.38
  59.19
  62.15
PV of cash for distribution, $m
  -722
  -567
  -434
  -323
  -231
  -158
  -102
  -61
  -31
  -12
  0
  0
  1
  3
  4
  3
  3
  2
  2
  1
  1
  0
  0
  0
  0
  0
  0
  0
  0
  0
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

CNO Financial Group, Inc. is a holding company for a group of insurance companies operating throughout the United States that develops, markets and administers health insurance, annuity, individual life insurance and other insurance products. The Company's segments include Bankers Life, Washington National and Colonial Penn. It sells health insurance, annuity, individual life insurance and other insurance products through three primary distribution channels: career agents, independent producers and direct marketing. The Company offers products in various categories, including health, annuities and life insurance. The health products include Medicare supplement, long-term care, prescription drug plan and Medicare advantage, supplemental health products and other health products. The annuities products include fixed index annuities and other fixed interest annuities. The life insurance products include interest-sensitive life products and traditional life products.

FINANCIAL RATIOS  of  CNO Financial Group (CNO)

Valuation Ratios
P/E Ratio 9.6
Price to Sales 0.9
Price to Book 0.8
Price to Tangible Book
Price to Cash Flow 4.5
Price to Free Cash Flow 4.5
Growth Rates
Sales Growth Rate 4.3%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate NaN%
Cap. Spend. - 3 Yr. Gr. Rate NaN%
Financial Strength
Quick Ratio NaN
Current Ratio NaN
LT Debt to Equity 94.1%
Total Debt to Equity 94.1%
Interest Coverage 0
Management Effectiveness
Return On Assets 1.1%
Ret/ On Assets - 3 Yr. Avg. 0.7%
Return On Total Capital 4.2%
Ret/ On T. Cap. - 3 Yr. Avg. 2.7%
Return On Equity 8.3%
Return On Equity - 3 Yr. Avg. 5.2%
Asset Turnover 0.1
Profitability Ratios
Gross Margin 0%
Gross Margin - 3 Yr. Avg. 0%
EBITDA Margin 8.8%
EBITDA Margin - 3 Yr. Avg. 7.5%
Operating Margin 11.7%
Oper. Margin - 3 Yr. Avg. 10%
Pre-Tax Margin 8.8%
Pre-Tax Margin - 3 Yr. Avg. 7.5%
Net Profit Margin 8.9%
Net Profit Margin - 3 Yr. Avg. 5.7%
Effective Tax Rate -1.4%
Eff/ Tax Rate - 3 Yr. Avg. 31.9%
Payout Ratio 15.4%

CNO stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the CNO stock intrinsic value calculation we used $4297 million for the last fiscal year's total revenue generated by CNO Financial Group. The default revenue input number comes from 2017 income statement of CNO Financial Group. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our CNO stock valuation model: a) initial revenue growth rate of 7.8% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 15.1%, whose default value for CNO is calculated based on our internal credit rating of CNO Financial Group, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of CNO Financial Group.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of CNO stock the variable cost ratio is equal to 78%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $338 million in the base year in the intrinsic value calculation for CNO stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for CNO Financial Group.

Corporate tax rate of 27% is the nominal tax rate for CNO Financial Group. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the CNO stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for CNO are equal to 757.3%.

Life of production assets of 10 years is the average useful life of capital assets used in CNO Financial Group operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for CNO is equal to -657.7%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $0 million for CNO Financial Group - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 170 million for CNO Financial Group is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of CNO Financial Group at the current share price and the inputted number of shares is $3.4 billion.

RELATED COMPANIES Price Int.Val. Rating
UNH UnitedHealth G 252.70 401.67  str.buy

COMPANY NEWS

▶ CNO: 1Q Earnings Snapshot   [Apr-25-18 06:34PM  Associated Press]
▶ New name coming for Bankers Life Fieldhouse in 2019   [Mar-13-18 01:28PM  Associated Press]
▶ CNO reports 4Q loss   [Feb-13-18 07:05PM  Associated Press]
▶ CNO Financial Names Two Vice Presidents   [Feb-05-18 03:00PM  PR Newswire]
▶ Understanding Analysts Ratings on MetLife   [Jan-24-18 07:30AM  Market Realist]
▶ Understanding MetLifes Discounted Valuations   [10:30AM  Market Realist]
▶ Analyzing the Performance of MetLifes EMEA Division   [Jan-22-18 10:31AM  Market Realist]
▶ How MetLifes US Division Has Performed   [Jan-19-18 10:34AM  Market Realist]
▶ MetLife Launches InsurTech Investment Programs   [Jan-18-18 03:00PM  Market Realist]
▶ What Can We Expect from MetLife in 4Q17?   [11:57AM  Market Realist]
▶ Analysts Views on MetLife   [09:00AM  Market Realist]
▶ How MetLifes Valuation Compares   [07:30AM  Market Realist]
▶ 6 Stocks Boosting Earnings and Revenue   [Dec-14-17 03:48PM  GuruFocus.com]
▶ Analyzing Prudentials Valuations after 3Q17   [Nov-29-17 10:31AM  Market Realist]
▶ CNO Financial Group Declares Quarterly Dividend   [Nov-16-17 04:15PM  PR Newswire]
▶ CNO beats 3Q profit forecasts   [Oct-25-17 06:59PM  Associated Press]
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.